For the Inventor, By the Inventor

Enter assignee name

Lexington, MA, United States of America

Inotek Pharmaceuticals Corporation

USPTO Granted Patents = 37

EPO Patents = 8

Forward Citations = 276

Loading Chart...

Loading Chart...

22 inventors (with patents filed for the assignee):

Prakash Jagtap (21 out of 33 patents)

Andrew L Salzman (17 out of 20 patents)

Csaba Szabo (16 out of 19 patents)

4. William K McVicar (10 out of 16 patents)

5. Thomas Mccauley (7 out of 15 patents)

6. Norman N Kim (7 out of 7 patents)

7. Garry Southan (7 out of 11 patents)

8. Siya Ram (5 out of 26 patents)

9. John Henry Van Duzer (5 out of 54 patents)

10. William Williams, Iii (4 out of 21 patents)

11. Alex Nivorozhkin (3 out of 28 patents)

12. Rudolf A Baumgartner (3 out of 3 patents)

13. Qi Zeng (3 out of 3 patents)

14. Erkan Baloglu (2 out of 34 patents)

15. Kanneganti Murthy (2 out of 2 patents)

37 patents: Sort by Forward Citations

1. 9718853 - Anhydrous polymorphs of [(2R,3S,4R,5R)-5-(6-(cyclopentylamino)-9H-purin-9-YL)-3,4-dihydroxytetrahydrofuran-2-YL)] methyl nitrate and processes of preparation thereof (2017-08-01),

2. 9522160 - Ophthalmic formulations (2016-12-20),

3. 9370530 - Combination, kit and method of reducing intraocular pressure (2016-06-21),

4. 9289383 - Method of reducing intraocular pressure in humans (2016-03-22),

5. 9278991 - Anhydrous polymorphs of [(2R,3S,4R,5R)-5-(6-(cyclopentylamino)-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)} methyl nitrate and processes of preparation thereof (2016-03-08),

6. 8895530 - Method of reducing intraocular pressure in humans (2014-11-25),

7. 8877732 - Combination, kit and method of reducing intraocular pressure (2014-11-04),

8. 8609833 - Purine derivatives as adenosine A1 receptor agonists and methods of use thereof (2013-12-17),

9. 8501708 - Adenosine compounds and their use thereof (2013-08-06),

10. 8476247 - Method of reducing intraocular pressure in humans (2013-07-02),

11. 8470800 - Method of reducing intraocular pressure in humans (2013-06-25),

12. 8455457 - Combination compositions for reducing intraocular pressure (2013-06-04),

13. 8440639 - Combination compositions for reducing intraocular pressure (2013-05-14),

14. 8263078 - Antibodies against flagellin and uses thereof (2012-09-11),

15. 8183224 - [object Object] (2012-05-22),

Inotek Pharmaceuticals Corporation is a biopharmaceutical company that develops and commercializes innovative therapies for the treatment of eye diseases. They focus on creating novel drugs that address the underlying causes of glaucoma and other ocular disorders. With a commitment to advancing patient care, Inotek Pharmaceuticals aims to make a positive impact on vision health worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

37 Patents

#28 in Lexington, MA

#523 in Massachusetts

#8,947 in US

#17,725 in the World

Lexington, MA, United States of America

Inotek Pharmaceuticals Corporation

Forward Citations = 276

22 inventors:

Prakash Jagtap (21 out of 33 patents)

Andrew L Salzman (17 out of 20 patents)

Csaba Szabo (16 out of 19 patents)

4. William K McVicar (10 out of 16 patents)

5. Thomas Mccauley (7 out of 15 patents)

Please report any incorrect information to support@idiyas.com

Loading…